Clinical Trials

Showing trials with last updates posted in 2026.

NCT06904066 | RECRUITING | PHASE1
86 participants

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-09-09
Completion:
2029-04-30
Conditions
  • Malignancy, Hematologic
  • Neoplasms, Hematologic
  • Neoplasms, Hematopoietic
  • Blood Cancer
  • Hematological Neoplasms
  • Hematopoietic Malignancies
  • Dysmyelopoietic Syndromes
  • Hematopoetic Myelodysplasia
  • Myeloid Leukemia, Acute
  • Nonlymphoblastic Leukemia, Acute
  • Leukemia, Lymphocytic, Acute
Interventions
  • DRUG
  • BIOLOGICAL
  • DEVICE
No Results Yet
NCT06902688 | ACTIVE_NOT_RECRUITING | NA
275 participants

Timely Ordering of Pharmacogenetic Testing

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2025-06-10
Completion:
2026-09-01
Conditions
  • Machine Learning
  • Prediction Models
  • Pediatrics
  • Precision Medicine
Interventions
  • OTHER
No Results Yet
NCT06886529 | ACTIVE_NOT_RECRUITING | NA
1000 participants

PACT Involvement in Cardiology Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2025-10-16
Completion:
2026-09-01
Conditions
  • Machine Learning
  • Cardiovascular Outcome
  • Pediatric Palliative Care
  • Pediatric Cardiology
Interventions
  • OTHER
No Results Yet
NCT06886451 | ACTIVE_NOT_RECRUITING | NA
1332 participants

Vomiting Prevention in Children With Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2025-03-18
Completion:
2026-09-02
Conditions
  • Chemotherapy Induced Nausea and Vomiting
  • Quality of Life (QOL)
  • Pediatric Cancer
Interventions
  • OTHER
No Results Yet
NCT06847815 | ACTIVE_NOT_RECRUITING | NA
45 participants

Glycemic Index of Sweet Corn

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2025-03-05
Completion:
2027-07-31
Conditions
  • Glycemic Index
Interventions
  • OTHER
No Results Yet
NCT06846606 | RECRUITING | PHASE1
69 participants

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2025-05-01
Completion:
2027-04-30
Conditions
  • Relapsed Acute Myeloid Leukemia (AML)
  • Refractory Acute Myeloid Leukemia (AML)
  • Relapsed/Refractory AML
  • Relapsed Myelodysplastic Syndromes
  • Refractory Myelodysplastic Syndromes
  • Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page